Michal Senitko, MD
Pulmonary Disease · Jackson, MSNPI 1336378637
Payments from drug & device makers
What this record shows
This record is dominated by education: $135,000 of the $184,643 with a category attached, or 73.1%. Intuitive Surgical accounts for 88.8% of it on its own, with 40 other manufacturers making up the rest. Reporting peaked in 2024 at $70,489 and has fallen 62.9% since, to $26,167 in 2025. Among pulmonary disease clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 428 payments — averaging $431.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$164K
- Pinnacle Biologics, Inc$11K
- Johnson & Johnson$2K
- Medtronic$2K
- Pulmonx Corporation$2K
- Pfizer$644
- plus $4K from 35 others
Across 9 payments — averaging $18,942 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galvanize Therapeutics, Inc$170K
What the payments were for
- Consulting fees$2,2001%
- Speaking & faculty fees$9,9005%
- Travel & lodging$22,10812%
- Food & beverage$15,4358%
- Education$135,00073%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$159,069
- Photofrin$9,715
- ION$3,000
- O-ARM-ST$1,800
- MONARCH$1,119
- Pulmonx Endobronchial Valve EBV$1,003
- ZEPHYR ENDOBRONCHIAL VALVE$400
- DA VINCI SP$400
- Spin$253
- VIO3 Cryo APC$128
- NUCALA$125
- UPTRAVI$112
- OPSUMIT$112
- Monarch Platform$103
How this compares
$184,643 in reported general payments places this provider in the 95th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jackson
- Demondes HaynesJackson$809K
- Andrew WilhelmJackson$51K
- Raymond PortisJackson$39K
- George AbrahamJackson$23K
- Maria RappaiJackson$20K
- Arash SamarghandiJackson$19K
- Kimberly DobbsJackson$14K
- Rajesh PatelJackson$13K
- Charles EvansJackson$12K
- Meredith SloanJackson$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.